Literature DB >> 29122287

Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.

Albert Liao1, Pardeep Mittal2, David H Lawson3, Jenny J Yang4, Eszter Szalai1, Hans E Grossniklaus5.   

Abstract

PURPOSE: The purpose of this study was to correlate magnetic resonance imaging (MRI) radiographic results with histopathologic growth patterns of metastatic uveal melanoma (UM) to the liver.
DESIGN: Clinicopathologic correlation. PARTICIPANTS: Patients with metastatic UM to the liver.
METHODS: A retrospective review of MRI images of patients with metastatic UM to the liver at a single institution between 2004 and 2016 was performed. The MRI growth patterns were classified as nodular or diffuse. The histopathologic findings of core liver biopsies of liver metastases identified by needle localization in a subset of these patients were reviewed. The core samples were evaluated by routine light microscopy, including immunohistochemical/immunofluorescent staining for CD31, CD105, and HMB45, and classified as exhibiting an infiltrative or nodular growth pattern. MAIN OUTCOME MEASURES: Magnetic resonance images and core biopsy findings.
RESULTS: A total of 32 patients were identified with metastatic UM to the liver that was imaged by MRI, and 127 lesions were identified. A total of 46 lesions were classified by MRI as infiltrative and 81 as nodular. There were 9 needle-localized core biopsies that corresponded to MRI of metastatic lesions. Of these 9 lesions, 3 that were classified as infiltrative on MRI exhibited stage I infiltrative histologic growth patterns; of the remaining 6 that were classified as nodular by MRI, 5 histologically demonstrated stage II or stage III infiltrative growth patterns and 1 histologically demonstrated a nodular growth pattern.
CONCLUSIONS: Magnetic resonance imaging of hepatic infiltrative growth patterns of metastatic UM corresponded to stage I histologic infiltrative growth in the sinusoidal spaces, whereas MRI nodular growth patterns corresponded to stage II/III histologic infiltrative growth that replaced the hepatic lobule or histologic nodular growth in the portal triad that effaced adjacent hepatic parenchyma.
Copyright © 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29122287      PMCID: PMC6211288          DOI: 10.1016/j.ophtha.2017.09.029

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  34 in total

1.  Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

Authors:  Michael D Onken; Lori A Worley; Rosa M Dávila; Devron H Char; J William Harbour
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

2.  Incidence of noncutaneous melanomas in the U.S.

Authors:  Colleen C McLaughlin; Xiao-Cheng Wu; Ahmedin Jemal; Howard J Martin; Lisa M Roche; Vivien W Chen
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

3.  Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma.

Authors:  John M Lattier; Hua Yang; Susan Crawford; Hans E Grossniklaus
Journal:  Clin Exp Metastasis       Date:  2013-06-22       Impact factor: 5.150

4.  Depletion of NK cell activity results in growth of hepatic micrometastases in a murine ocular melanoma model.

Authors:  S A Dithmar; D A Rusciano; C A Armstrong; M J Lynn; H E Grossniklaus
Journal:  Curr Eye Res       Date:  1999-11       Impact factor: 2.424

5.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 6.  Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.

Authors:  Shenghui Xue; Jingjuan Qiao; Fan Pu; Mathew Cameron; Jenny J Yang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-01-17

7.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

8.  Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.

Authors:  Maria M Choudhary; Akshay Gupta; James Bena; Todd Emch; Arun D Singh
Journal:  JAMA Ophthalmol       Date:  2016-02       Impact factor: 7.389

Review 9.  Molecular prognostic testing and individualized patient care in uveal melanoma.

Authors:  J William Harbour
Journal:  Am J Ophthalmol       Date:  2009-10-02       Impact factor: 5.258

10.  Endoglin - a marker of vascular endothelial cell proliferation in cancer.

Authors:  Ewa Kopczyńska; Roman Makarewicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29
View more
  6 in total

Review 1.  CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.

Authors:  Shenglin Li; Zhengxiao Li; Xiaoyu Huang; Peng Zhang; Juan Deng; Xianwang Liu; Caiqiang Xue; Wenjuan Zhang; Junlin Zhou
Journal:  Abdom Radiol (NY)       Date:  2022-07-27

2.  Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging.

Authors:  Hua Yang; Shanshan Tan; Jingjuan Qiao; Yiting Xu; Zongxiang Gui; Yuguang Meng; Bin Dong; Guangda Peng; Oluwatosin Y Ibhagui; Weiping Qian; Jimmy Lu; Zezhong Li; Guimin Wang; Jinping Lai; Lily Yang; Hans E Grossniklaus; Jenny J Yang
Journal:  Cancer Gene Ther       Date:  2022-02-10       Impact factor: 5.854

3.  Growth Pattern of Hepatic Metastasis as a Prognostic Index Reflecting Liver Metastasis-Associated Survival in Breast Cancer Liver Metastasis.

Authors:  Jieun Lee; Moonhyung Choi; Seungyeon Joe; Kabsoo Shin; Sung-Hak Lee; Ahwon Lee
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

4.  Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.

Authors:  Raymond Barnhill; Peter Vermeulen; Sofie Daelemans; Pieter-Jan van Dam; Sergio Roman-Roman; Vincent Servois; Ilse Hurbain; Sophie Gardrat; Graça Raposa; André Nicolas; Rémi Dendale; Gaëlle Pierron; Laurence Desjardins; Nathalie Cassoux; Sophie Piperno-Neumann; Pascale Mariani; Claire Lugassy
Journal:  J Pathol Clin Res       Date:  2018-08-23

Review 5.  The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns.

Authors:  Gemma Garcia-Vicién; Artur Mezheyeuski; María Bañuls; Núria Ruiz-Roig; David G Molleví
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

6.  Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases.

Authors:  Shanshan Tan; Hua Yang; Shenghui Xue; Jingjuan Qiao; Mani Salarian; Khan Hekmatyar; Yuguang Meng; Rao Mukkavilli; Fan Pu; Oluwatosin Y Odubade; Wayne Harris; Yan Hai; Melinda L Yushak; Vanessa M Morales-Tirado; Pardeep Mittal; Phillip Z Sun; David Lawson; Hans E Grossniklaus; Jenny J Yang
Journal:  Sci Adv       Date:  2020-02-07       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.